Elias Kouchakji, MD: Greatest Unmet Need in Duchenne Muscular Dystrophy
October 14th 2020The senior vice president of clinical development, drug safety, and pharmacovigilance at FibroGen discussed why turning Duchenne muscular dystrophy into a chronic disease rather than a fatal one, is a top priority.